|
1
|
Siegel R, Desantis C and Jemal A:
Colorectal cancer statistics, 2014. CA Cancer J Clin. 64:104–117.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Benito M and Díaz-Rubio E: Molecular
biology in colorectal cancer. Clin Transl Oncol. 8:391–398. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Parks SK, Chiche J and Pouyssegur J: pH
control mechanisms of tumor survival and growth. J Cell Physiol.
226:299–308. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Swietach P, Patiar S, Supuran CT, Harris
AL and Vaughan-Jones RD: The role of carbonic anhydrase 9 in
regulating extracellular and intracellular pH in three-dimensional
tumor cell growths. J Biol Chem. 284:20299–20310. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Doherty JR and Cleveland JL: Targeting
lactate metabolism for cancer therapeutics. J Clin Invest.
123:3685–3692. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Semenza GL: Tumor metabolism: Cancer cells
give and take lactate. J Clin Invest. 118:3835–3837.
2008.PubMed/NCBI
|
|
7
|
Kato Y, Ozawa S, Miyamoto C, Maehata Y,
Suzuki A, Maeda T and Baba Y: Acidic extracellular microenvironment
and cancer. Cancer Cell Int. 13:892013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Swietach P, Vaughan-Jones RD and Harris
AL: Regulation of tumor pH and the role of carbonic anhydrase 9.
Cancer Metastasis Rev. 26:299–310. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
McDonald PC, Winum JY, Supuran CT and
Dedhar S: Recent developments in targeting carbonic anhydrase IX
for cancer therapeutics. Oncotarget. 3:84–97. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gu MJ and Kwon KW: Carbonic anhydrase IX
expression is associated with favorable prognostic factors in small
intestinal carcinoma. J Histochem Cytochem. 62:205–210. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
McIntyre A, Patiar S, Wigfield S, Li JL,
Ledaki I, Turley H, Leek R, Snell C, Gatter K, Sly WS, et al:
Carbonic anhydrase IX promotes tumor growth and necrosis in
vivo and inhibition enhances anti-VEGF therapy. Clin Cancer
Res. 18:3100–3111. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dubois L, Peeters S, Lieuwes NG, Geusens
N, Thiry A, Wigfield S, Carta F, McIntyre A, Scozzafava A, Dogné
JM, et al: Specific inhibition of carbonic anhydrase IX activity
enhances the in vivo therapeutic effect of tumor
irradiation. Radiother Oncol. 99:424–431. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chiche J, Ilc K, Laferrière J, Trottier E,
Dayan F, Mazure NM, Brahimi-Horn MC and Pouysségur J:
Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell
growth by counteracting acidosis through the regulation of the
intracellular pH. Cancer Res. 69:358–368. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nguyen TT and Bonanno JA: Bicarbonate,
NBCe1, NHE, and carbonic anhydrase activity enhance lactate-H+
transport in bovine corneal endothelium. Invest Ophthalmol Vis Sci.
52:8086–8093. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nakayama Y, Torigoe T, Inoue Y, Minagawa
N, Izumi H, Kohno K and Yamaguchi K: Prognostic significance of
monocarboxylate transporter 4 expression in patients with
colorectal cancer. Exp Ther Med. 3:25–30. 2012.PubMed/NCBI
|
|
16
|
Dimmer KS, Friedrich B, Lang F, Deitmer JW
and Bröer S: The low-affinity monocarboxylate transporter MCT4 is
adapted to the export of lactate in highly glycolytic cells.
Biochem J. 350:219–227. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gotanda Y, Akagi Y, Kawahara A, Kinugasa
T, Yoshida T, Ryu Y, Shiratsuchi I, Kage M and Shirouzu K:
Expression of monocarboxylate transporter (MCT)-4 in colorectal
cancer and its role: MCT4 contributes to the growth of colorectal
cancer with vascular endothelial growth factor. Anticancer Res.
33:2941–2947. 2013.PubMed/NCBI
|
|
18
|
Hussien R and Brooks GA: Mitochondrial and
plasma membrane lactate transporter and lactate dehydrogenase
isoform expression in breast cancer cell lines. Physiol Genomics.
43:255–264. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lou Y, McDonald PC, Oloumi A, Chia S,
Ostlund C, Ahmadi A, Kyle A, dem Keller Auf U, Leung S, Huntsman D,
et al: Targeting tumor hypoxia: Suppression of breast tumor growth
and metastasis by novel carbonic anhydrase IX inhibitors. Cancer
Res. 71:3364–3376. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pacchiano F, Carta F, McDonald PC, Lou Y,
Vullo D, Scozzafava A, Dedhar S and Supuran CT: Ureido-substituted
benzenesulfonamides potently inhibit carbonic anhydrase IX and show
antimetastatic activity in a model of breast cancer metastasis. J
Med Chem. 54:1896–1902. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Draoui N and Feron O: Lactate shuttles at
a glance: From physiological paradigms to anti-cancer treatments.
Dis Model Mech. 4:727–732. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zheng J: Energy metabolism of cancer:
Glycolysis versus oxidative phosphorylation (Review). Oncol Lett.
4:1151–1157. 2012.PubMed/NCBI
|
|
23
|
Touisni N, Maresca A, McDonald PC, Lou Y,
Scozzafava A, Dedhar S, Winum JY and Supuran CT: Glycosyl coumarin
carbonic anhydrase IX and XII inhibitors strongly attenuate the
growth of primary breast tumors. J Med Chem. 54:8271–8277. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Klier M, Andes FT, Deitmer JW and Becker
HM: Intracellular and extracellular carbonic anhydrases cooperate
non-enzymatically to enhance activity of monocarboxylate
transporters. J Biol Chem. 289:2765–2775. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ditte Z, Ditte P, Labudova M, Simko V,
Iuliano F, Zatovicova M, Csaderova L, Pastorekova S and Pastorek J:
Carnosine inhibits carbonic anhydrase IX-mediated extracellular
acidosis and suppresses growth of HeLa tumor xenografts. BMC
Cancer. 14:3582014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lim KS, Lim KJ, Price AC, Orr BA, Eberhart
CG and Bar EE: Inhibition of monocarboxylate transporter-4 depletes
stem-like glioblastoma cells and inhibits HIF transcriptional
response in a lactate-independent manner. Oncogene. 33:4433–4441.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kim MY, Zhang T and Kraus WL:
Poly(ADP-ribosyl)ation by PARP-1: ‘PAR-laying’ NAD+ into a nuclear
signal. Genes Dev. 19:1951–1967. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zanke BW, Lee C, Arab S and Tannock IF:
Death of tumor cells after intracellular acidification is dependent
on stress-activated protein kinases (SAPK/JNK) pathway activation
and cannot be inhibited by Bcl-2 expression or interleukin
1beta-converting enzyme inhibition. Cancer Res. 58:2801–2808.
1998.PubMed/NCBI
|
|
29
|
Lagadic-Gossmann D, Huc L and Lecureur V:
Alterations of intracellular pH homeostasis in apoptosis: Origins
and roles. Cell Death Diff. 11:953–961. 2004. View Article : Google Scholar
|
|
30
|
Thammasit P, Sangboonruang S, Suwanpairoj
S, Khamaikawin W, Intasai N, Kasinrerk W, Tayapiwatana C and
Tragoolpua K: Intracellular Acidosis promotes mitochondrial
apoptosis pathway: Role of EMMPRIN down-regulation via specific
single-chain Fv intrabody. J Cancer. 6:276–286. 2015. View Article : Google Scholar : PubMed/NCBI
|
